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ABSTRACT 
 
Identifying and Mapping Parallel Mutations of GAR-3. (April 2009) 
 
Christopher Prompuntagorn 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. Luis Rene Garcia 
Department of Biology 
 
This research identifies a gene that potentially works acetylcholine receptor protein 
GAR-3.  We isolated nematodes (roundworm) Caenorhabditis elegans that are resistant 
to the drug arecoline, which stimulates behaviors such as spicule protraction (mating 
behavior).  From the isolated worms we created about thirty recombinants, crossing 
arecoline resistant mutants genetically wildtype worms, and collected their DNA.  
Testing the chromosomes at different loci can identify a locus that contains mutant 
DNA; regions of the chromosome that display wildtype DNA are ruled out.  An online 
catalog of single nucleotide polymorphisms allows us to distinguish between the 
wildtype (HA) and mutant (N2) DNA; there are regions that contain a single base pair 
difference between the N2 and HA samples.  We amplified many DNA regions with 
polymerase chain reaction and tested each region with a restriction endonuclease that cut 
either the wildtype or the mutant DNA. We observed each recombinant’s restriction 
pattern on agarose gel to determine which regions contain 100 percent mutant DNA and 
could thus statistically be the site of the mutation.  We believe the mutation lies in a 
  iv 
region on the left end of the X chromosome, based on a larger proportion of N2 DNA 
compared to regions on the rest of the chromosomes.  We believe we can use this data to 
narrow down the genes in this region and pinpoint which mutation is causing the 
nonfunctional protein. 
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NOMENCLATURE 
 
N2 Bristol C. elegans 
HA Hawaii C. elegans 
ACh Acetylcholine 
mAChR Muscarinic Acetylcholine Receptor 
LG I Linkage Group 1 on Chromosome 1 
LG II Linkage Group 2 on Chromosome 2 
LG III Linkage Group 3 on Chromosome 3 
LG IV Linkage Group 4 on Chromosome 4 
LG V Linkage Group 5 on Chromosome 5 
LG X Linkage Group X on Chromosome X 
PCR Polymerase Chain Reaction 
SNP Single Nucleotide Polymorphism 
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CHAPTER I 
INTRODUCTION 
 
Understanding how molecules control biological pathways can help relate everyday 
behaviors such as completing a task.  This research demonstrates how neuronal circuits 
can control a behavior.  For experiments regarding animal behavior, a good model 
should be easy to manipulate and observe.  A relatively simple animal with a few 
observable and quantifiable behaviors is the roundworm Caenorhabditis elegans.  This 
worm is 1 millimeter in length, almost invisible to the naked eye.  Thus behavior must 
be studied under a microscope.  Those that have two X chromosomes develop as 
hermaphrodites, while those with one X chromosome develop as males.  The males are 
posed with the task of mating to pass their genes to subsequent generations, while 
hermaphrodites do not require such mating for their genes to be passed on.  Simple 
survival mechanism behaviors are easy to observe with C. elegans. Furthermore, 
because of the ease of obtaining DNA for testing, C. elegans makes as an excellent 
scientific model.  Studying a behavior such as male mating behavior allows us to explore 
biological processes in detail.  These processes can be further dissected with genetic 
mutations to understand the molecules that regulate how neurons and muscles work. 
 
_______________ 
This thesis follows the style of The Journal of Neuroscience. 
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Observed behaviors 
We are exploring molecular pathways that promote neuromuscular activities, which are 
required to complete a goal-oriented behavior.  One can artificially stimulate a behavior 
with chemicals or drugs.  When exposed to the drug arecoline, certain receptors activate.  
The activation leads to particular physical actions in organisms; in the case of male C. 
elegans, spicule protractor muscle contraction.  Acetylcholine (ACh) receptors are 
respond to neurotransmitters (such as ACh) to complete activities such as synaptic 
transmission and muscular contraction (Marieb and Hoehn, 2006).  There are two types 
of ACh receptors: nicotinic and muscarinic.  The nicotinic ACh receptors, which are 
activated by nicotine, are ligand gated ion channels, whereas muscarinic ACh receptors 
are metabotropic G-protein coupled receptors (Sargent, 1993).  The latter can be 
stimulated by muscarine, and also the drug arecoline. 
 
C. elegans male mating behavior consists of multiple sensory and motor steps.  One of 
these steps is the insertion of the male sex organ (called the spicule) into the vulva of his 
hermaphroditic mate.  A neuromuscular circuit, consisting of spicule protractor muscles 
and their associated neurons, controls the movement of the spicules during mating.  A 
molecule expressed in this circuit is the muscarinic acetylcholine receptor (mAChR).  
Neuronal cells in the circuit contain mAChR proteins.  One example of a mAChR 
protein is GAR-3, which is known to be a G-protein coupled receptor on the cell 
membrane (Steger and Avery, 2004). 
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Drugs such as arecoline and oxotremorine are agonists to mAChR receptors.  An agonist 
is drug that can combine with a receptor on a cell to produce a physiological reaction, 
such as muscle contraction or synaptic transmission. When mAChRs are stimulated, G-
proteins activate their effectors, which cause cells to produce an output.  G-protein 
activation involves subunit Gα dissociating from Gβγ, which activates other enzymes like 
adenylate cyclase (Aperia et al., 1994; Alberts et al., 2003) and lead to further cellular 
responses.  In the case of males, activating GAR-3 with drugs promotes spicule 
protractor muscle contracting, and consequently male worms display mating behavior 
(Liu et al., 2007).   
 
Experimental basis 
Wild type male C. elegans mate by inserting their spicules into a hermaphrodite’s vulva. 
Arecoline will make males stick their spicules out.  However, if GAR-3 is mutated, 
fewer male worms display the extension of spicules at a concentration of arecoline that 
would make 100% of wildtype worms protract their spicules. Lack of GAR-3 partially 
impairs male C. elegans’ ability to continuously protract their spicules (Garcia et al., 
2001).  However, arecoline-induced spicule protraction is not completely inhibited, 
suggesting that other genes contribute to alternative pathways that promote spicule 
muscle contraction.  We identified another mutation that, in conjunction with a deletion 
of GAR-3, displays even more arecoline resistance.  We refer to this mutation as rg430. 
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What we did not know is where this mutation maps in the genome of C. elegans.  To 
find where the rg430 mutation maps, we made hybrids between rg430 mutants and 
Hawaiian wildtype variants.  We homozygosed the arecoline-resistant phenotypes, and 
by single-nucleotide polymorphism mapping we genotyped which chromosomes did not 
contain the rg430 mutation.  Here I report that the rg430 mutation maps to the C. 
elegans X chromosome, and discuss further work on identifying the molecular identity 
of the gene affected by rg430.  
 
Scientific significance 
GAR-3 is a muscarinic acetylcholine receptor found in animals, with a genetic sequence 
similar to the sequence in the mammalian genome. The neurological pathway circuitry 
of C. elegans is analogous to those found in higher organisms, suggesting that there is a 
link between the worm behavior and behavioral mechanisms in higher organisms.  
Therefore, mapping the gene with the mutation rg430 may possibly identify a similar 
gene that is used in behaviors of other animal species. 
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CHAPTER II 
METHODS 
 
To create recombinant DNA, we crossed two genetically divergent lines of C. elegans; 
one from Bristol, United Kingdom (N2) and the other from Hawaii (HA).  To ensure the 
recombined males were homozygous for rg430, Dr. Garcia screened each of the mutant 
worms with the drug arecoline; this was done in the summer of 2008, and this is where I 
picked up the project.  Screening the N2/Hawaii hybrids for arecoline resistance 
identified worms with recombined Hawaiian DNA shuffled in, but still have N2 DNA at 
the site of the mutation. 
 
C. elegans is a species with multiple variants, many of which display a single different 
nitrogenous base (single nucleotide polymorphism) in a given sequence of DNA.  Many 
SNPs exist between the N2 variant and, according to Koch et al. in Genome Research, 
an “isolate from an island (Hawaii) that contains many unique SNPs… from the rest of 
the world” (Koch et al., 2000).   
 
We wanted to homozygose the mutation to rule out the regions of a chromosome that did 
not have the mutation allele.  SNP mapping accomplishes this by eliminating regions of 
the chromosome that do not contribute to the mutant phenotype.  In our case, crossing in 
a wildtype Hawaiian genome will rule out the regions containing Hawaii-characteristic 
SNPs, since the mutation is homozygosed on the N2. 
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We homozygosed the rg430 mutation by isolating a line of N2 worms resistant to 
arecoline; the Hawaii line was wildtype.  We crossed these two lines together to form the 
F1 generation (phenotypically wildtype).  After producing the N2/HA heterozygous F1 
generation, we allowed them to self-reproduce to form the F2.  From the F2 generation 
we picked out those resistant to arecoline, since the drug is the agonist for the GAR-3 
protein as well as the unknown functioning unit affected by the mutation rg430. 
 
We had 28 different samples of recombinant lines (five of the samples did not last for 
more than two weeks, so the final table on page 13 shows 23 lines).  Various primers for 
regions on the six different chromosomes were used to amplify the C. elegans DNA 
using polymerase chain reaction (PCR) to screen those regions.  I prepared the samples 
by lysing the worms with protease K lysis solution to obtain DNA in solution.  Protease 
K is a serine protease that digests the cell’s proteins to yield exposed DNA in solution 
(Ebeling et al., 1974).  Once the lysis protocol was completed, I amplified the sample 
DNA with 30 cycles of PCR.  I mixed Taq DNA Polymerase purchased from New 
England Biolabs, Thermopol Buffer, dNTP solution, and water.  I added the appropriate 
primer (see Appendix B) for the segment I was amplifying as well as 5 µL of the worm 
DNA solution each of the samples. 
 
To amplify the 50 µL PCR mixtures I created a program on the lab’s PCR machine to 
start the reaction at 92 °C for two minutes.  I then programmed a cycle of 92 °C for 30 
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seconds, annealing at 50-60 °C (depending on salt-adjusted Tm Calculations for Oligos, 
http://www.promega.com/biomath/calc11.htm), and 68 °C for one minute.  This cycle 
was repeated 29 more times for 30 total cycles. 
 
We referred to an online Single Nucleotide Polymorphism (SNP) catalogue 
(http://genome.wustl.edu/genome/celegans/celegans_snp.cgi) to distinguish the DNA as 
coming from N2 or Hawaiian parental DNA.  From this catalogue I also ordered primers 
on either side of the SNP site that were unique to that SNP site (see Appendix B).  We 
took advantage of these SNPs by using restriction enzymes (Figures 1 through 9) that cut 
one variant’s sequence but not the other variant’s sequence due to the single different 
base at the restriction site. 
 
After cleaning the PCR product DNA, I mixed it with a restriction enzyme, determined 
by the information in this SNP catalogue as well as the appropriate buffer for the 
enzyme.  I incubated the tubes of rectriction enzyme, buffer, and DNA at the appropriate 
temperature (usually 37 °C) for 1.5 – 2 hours.  I ran the samples with a 1 kb ladder on an 
8% agarose gel, usually at a voltage of around 40-60 mV, until I could observe decent 
separation of the DNA bands of interest.   
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The mutation would lie somewhere that contains only the DNA from the N2 line, so I 
was interested in regions with N2 restriction patterns.  Finding regions of heterozygous 
or Hawaiian DNA on an agarose gel would rule out that region for the mutant gene of 
interest. 
 
I started with linkage group 1 (LG I), which contains genes found throughout the entire 
DNA from chromosome 1.  I sampled a region on each end of the chromosome using the 
SNP mapping technique described above to determine if there was Hawaii DNA present.  
I usually ruled out the chromosome if I found around half of the samples showing 
Hawaii homozygous or heterozygous DNA.  I repeated this for all of the chromosomes 
(except LG V).  Only a small segment on chromosome X displayed 100% N2 DNA, 
suggesting a genetic linkage to the rg430 mutation allele. 
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CHAPTER III 
RESULTS 
 
Screening linkage groups 
We used data from restriction sites on DNA regions with single nucleotide 
polymorphisms to screen the chromosomes of C. elegans.  Chromosomes 1 through 5 
had no SNPs with N2-rich regions that were common to all the recombinants.  I did not 
screen LG V; Dr. Garcia informed me that he had extensively studied the genes on 
chromosome 5 already when studying GAR-3 in a past experiment, and that the 
mutation rg430 cannot be linked to the fifth chromosome.  For regions on the remaining 
chromosomes, most of the gels showed up with significant percentages of samples 
displaying heterozygous or homozygous Hawaiian DNA, thus ruling out the 
chromosome.  As mentioned earlier, I disregarded as possible candidates the linkage 
groups where I had gels with ≈ 50% of the samples displaying N2 DNA.   Figures 1 
through Figure 6 shows some of the restriction bands from each linkage group: 
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Ladder 
N2 control 
3-31 N2 
3-42 N2 
3-11 Het 
3-13 HA 
3-49 Het 
Ladder 
7-9 N2 
7-12 N2 
8-12 HA 
10-3 N2 
11-1 N2 
6-3 HA 
 
 
N2 control 
Ladder 
3-24 N2 
3-31 HA 
3-42 N2 
3-11 none 
3-13 HA 
2-9 Het 
2-20 Het 
Ladder 
5-5 HA 
5-1 N2 
5-2 HA 
5-9 Het 
5-33 HA 
 
 
Ladder 
N2 control 
1-23  N2 
1-29  Het 
1-20 HA 
1-40 HA 
3-42 N2 
2-9 HA 
3-24 N2 
 
 
Ladder 
N2 control 
1-23  Het 
1-29  N2 
1-7 Het 
1-20 Het 
1-40 N2 
Ladder 
5-1 N2 
7-9 Het 
7-12 Het 
8-12 Both 
10-3 N2 
11-1 Both 
6-3 HA 
4-21 N2 
 
 
Figure 2: LG II 
F45E12 (Right End) 
Digest with ApoI 
N2 = 250 & 130 bp 
HA = 380 bp 
 
 
Figure 4: LG IV 
Y105C5B (Right End) 
Digest with DraI 
N2 = 200 & 100 bp 
HA = 300 bp 
Figure 3: LG III 
Y111B2A (Right End) 
Digest with Mse1 
N2 = 525 bp 
HA = 270 bp 
 
Figure 1: LG I 
ZK909 (Right End) 
Digest with HindIII 
N2 = 450 bp (base pairs) 
HA = 250 bp 
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However, upon initial sampling of the left end of chromosome X, at region F49H12, a 
significant majority of the recombinant DNA showed a restriction pattern as N2 
homozygous.  Upon completion of screening the region F49H12 located at the left end 
of region 3 of chromosome X, about two-thirds to three-quarters of the recombinant 
samples showed N2 homozygous DNA.  I decided to focus on this region because the 
agarose gel of DNA restrictions had 100% N2 DNA.  
 
I also screened the surrounding segments.  To the right, on segment 3 of chromosome X, 
region T24D8 also had a high percentage of N2 homozygous DNA, with a few more 
chiasma (crossing over) regions where N2 homozygous DNA became either HA/N2 
heterozygous or HA homozygous regions.   
 
 
 
Ladder 
4-21 N2 
Ladder 
N2 control 
1-12 N2 
1-23 HA 
1-29 N2 
1-8 None 
1-20 N2 
1-40 Het 
7-9 HA 
10-3 HA 
11-1 N2 
6-3 HA 
 
 
Figure 6: LG X 
(F49H12) 
Digest with DraI 
 
N2 control 
Ladder 
3-24 N2 
3-31 N2 
3-42 N2 
3-11 N2 
3-13 N2 
3-49 N2 
Ladder 
2-9 N2 
2-20 N2 
5-5 N2 
5-1 N2 
5-2 N2 
5-9 N2 
5-33 N2 
 
 
 
Figure 5: LG X  
(F49H12 Left End) 
Digest with DraI 
N2 = 470 bp 
HA = 250 bp 
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To the left of region F49H12, region F09E10 on segment 2 of chromosome X is even 
more N2-rich.  I have confirmed that 100% of my 23 samples in this region have N2 
homozygous DNA.  Furthermore, DNA bands indicative of Hawaiian DNA are present 
on gels analyzing segment W05H7, which is further left than F09E10 on the X 
chromosome; W05H7 is the left border and F49H12 is the right border for possible gene 
candidates.  This means we can hypothesize which genes in this region contain the 
mutation for the nonfunctional protein. 
 
Discussion 
The results from my experiments suggest that the mutation is located between region 
W05H7 and F49H12, possibly close to the region F09E10, since it showed all N2 DNA.  
Table 1  includes the crossing over data between regions W05H7 and T24D8.  
 
 
 
Figure 8: LG X (F09E10) 
Left of F49H12 
Digest with Bfa1 
N2 bands = 800 bp 
All bands are N2 
 
Figure 7: LG X (T24D8) 
Digest with Nci1 
N2 bands = 500 bp 
HA = 250 bp 
(Right of F49H12) 
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Table 1: Recombinant DNA Clones on LG X 
 
 Clone Segment 
 
 
 W05H7  F09E10 (S2R) F49H12 (S3L) T24D8 (S3R) 
R
ec
om
bi
na
nt
 N
um
be
r 
1--23 HA | HA x N2 | N2 x HA | HA  HA | HA 
1--29 N2 | HA  N2 | N2  N2 | N2  N2 | N2 
1--20 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
1--40 N2 | HA x N2 | N2 x N2 | HA  N2 | HA 
3--42 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
2--9 N2 | HA x N2 | N2  N2 | N2 x N2 | HA 
5--1 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
5--2 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
5--5 N2 | HA x N2 | N2  N2 | N2  N2 | N2 
5--9 N2 | HA x N2 | N2  N2 | N2  N2 | N2 
5--33 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
11--1 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
3--11 HA | HA x N2 | N2  N2 | N2  N2 | N2 
3--24 HA | HA x N2 | N2  N2 | N2 x HA | HA 
1--8 HA | HA x N2 | N2 x HA | HA  HA | HA 
7--9 HA | HA x N2 | N2 x HA | HA  HA | HA 
7--12 HA | HA x N2 | N2 x HA | HA  HA | HA 
8--12 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
10--3 HA | HA x N2 | N2  HA | HA  HA | HA 
6--3 HA | HA x N2 | N2  HA | HA  HA | HA 
4--21 N2 | N2  N2 | N2  N2 | N2 x N2 | HA 
3--31 N2 | N2  N2 | N2  N2 | N2  N2 | N2 
3--49 HA | HA x N2 | N2  HA | HA  HA | HA 
 
 
• X indicates chiasma (crossing over) location in between 2 SNP regions. Bold indicates double 
crossovers that result in a region of N2 DNA “flanked” by Hawaii DNA 
• W05H7 = segment 2 center; F09E10 = segment 2 right; F49H12 = segment 3 left;  
T24D8 = segment 3 right 
• W05H7, F09E10, F49H12, etc. are names of cloned sequences  
• The sequences that are located in regions that contain SNP  
• Genes in that region are named after the clone sequence 
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Genes mapped to the region between W05H7 and F49H12 are potential candidates that 
might be linked to rg430.  Appendix A lists all the genes mapped in this region (W05H7 
to F49H12) of the C. elegans genome.  Since the region with the clone segment F09E10 
displayed all N2 DNA, I can explore the genes in the immediate vicinity of that segment 
and continue screening genes outward in both directions, using the recombinants 
“flanked” with HA homozygous or heterozygous DNA on both sides of the regions. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
I have narrowed down a region where mutation rg430 may map.  This region exists 
between segments W05H7 and F49H12; many genes in this region have relevant 
molecular identities. Some of the notable genes are: rgs-9 (ZC53.7) = regulator of G 
protein signaling; rgs-8.2 (Y59E1A.2) = regulator of G protein signaling; rgs-8.1 
(F52D2.2) = regulator of G protein signaling; and str-79 (F52D2.9) = Seven TM 
Receptor.  Since GAR-3 (which maps to LG V) is a seven trans-membrane G-protein 
coupled receptor, then a parallel mutation could be something similar in nature on 
chromosome X.   
 
 
 
SNP restriction sites (areas where I could distinguish N2 and HA with PCR and 
restriction enzyme digestion) do not exist in this region, but SNP sites that can be 
distinguished by DNA sequencing exist in this interval.  Therefore we must continue to 
sequence the genes in the samples that are N2, flanked on both sides by N2HA 
chiasma points.  In addition, we can also sequence candidate genes in the rg430 
mutation region and compare them with a database of mapped genes to determine if the 
Figure 9: Visual Map of Region with rg430 
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candidate gene contains a base pair change.  Wormbase.org, a website that contains 
databases for C. elegans molecular biology, has a database of mapped genes.  We may 
proceed to create PCR primers for the gene’s sequence to be amplified in the worms.  
Then we can match the sequence of the gene with the recombinants’ sequences to see if 
there is a mutated gene in any of the recombinants’ genome. 
 
This research has covered the process of identifying a phenotype linked to a neural 
circuit that is responsible for goal-oriented behavior, such as mating behavior.  
Screening chromosomes of C. elegans using SNP mapping has narrowed down a region 
on the X chromosome with several genes.  We will be able to sequence within this 
region to determine which gene ultimately contributes to the mutation rg430. 
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APPENDIX A 
Table 2: List of Genes Mapped to Region with rg430 
 
W05H7 boundary F07G6.5 mir-1018 (Y59E1B.3
D1005.3 fbxa-52 (F07G6.5) B0294.3 
D1005.2 F07G6.9 B0294.1 
D1005.6 fbxa-53 (F07G6.7) ZC53.1 
D1005.5 F07G6.8 rgs-9 (ZC53.7)
D1005.1 F07G6.3 ZC53.6 
D1005.4 F07G6.2 ZC53.2 
dhs-25 (F09E10.3) dgn-3 (F07G6.1) ZC53.4 
F09E10.5 F07G6.10 fbxa-40 (Y59E1A.1)
F09E10.6 Y75D11A.2 rgs-8.2 (Y59E1A.2)
F09E10.7 Y75D11A.3 fbxa-41 (F52D2.1) 
F09E10.1 Y75D11A.6 rgs-8.1 (F52D2.2)
tts-1 (F09E10.11) Y75D11A.1 fbxa-17 (F52D2.10)
F09E10.10 Y75D11A.5 F52D2.7 
toca-1 (F09E10.8) elc-2 (W03H1.2) str-79 (F52D2.9)
K06A9.3 fbxc-37 (F31A9.4) F52D2.5 
K06A9.2 arg-1 (F31A9.3) F52D2.6 
K06A9.1 F31A9.2 fbxa-46 (F52D2.8) 
H02F09.3 F31A9.1 gei-12 (F52H2.4) 
H02F09.2 mir-796 (C14E2.8) Y40A1A.2 
wrt-9 (B0344.2) C14E2.2 Y40A1A.3 
H11E01.3 C14E2.7 Y40A1A.1 
H11E01.2 C14E2.4 Y102A11A.9 
fbxb-58 (H11E01.1) C14E2.5 Y102A11A.2 
ZK380.5 C14E2.1 Y102A11A.5 
ZK380.4 C14E2.6 Y102A11A.6 
tbx-32 (ZK380.1) T26C11.2 Y102A11A.7 
R09H3.1 T26C11.3 Y102A11A.8 
R09H3.3 T26C11.4 Y102A11A.1 
tbx-31 (C36C9.2) ceh-41 (T26C11.5) F49H12 boundary 
fbxa-170 (C36C9.3) ceh-21 (T26C11.6) 
C36C9.1 ceh-39 (T26C11.7) 
C36C9.6 T26C11.8  
C36C9.4 tbx-41 (T26C11.1) 
C36C9.5 Y59E1B.2  
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APPENDIX B 
Table 3: Primers for SNP Mapping 
 
Segment Primer  Anneals Sequence 
W05H7 
FW05H7 59 °C TCTAAGTTGAAAAGTATGTATACTCTCGATGCACCGTACTC
RW05H7 59 °C GCCGACGAGGGAATCAAGCAATTTTTCCAGGTA 
F09E10 
F09E10F 56 °C CGGGGTTTCGCATACTTTTAATGATTTAGAGTCAT 
F09E10R 57 °C calc*
56 °C used
CGGAAAGTGAGGTGGTGACAATAATCTCCT 
F49H12 
FF49H12 53 °C calc*
51 °C used
ATGTGAGTTTACCATCACTGGG 
F49H12R 51 °C TTTCGTAAAACTTACCGAGCAC 
*Calculated Tm using http://www.promega.com/biomath/calc11.htm  
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